PortfoliosLab logo
ALT vs. METCB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALT and METCB is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ALT vs. METCB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

ALT:

-0.20

METCB:

-0.45

Sortino Ratio

ALT:

0.31

METCB:

-0.68

Omega Ratio

ALT:

1.03

METCB:

0.92

Calmar Ratio

ALT:

-0.16

METCB:

-0.52

Martin Ratio

ALT:

-0.53

METCB:

-1.87

Ulcer Index

ALT:

30.57%

METCB:

15.83%

Daily Std Dev

ALT:

83.28%

METCB:

48.17%

Max Drawdown

ALT:

-99.94%

METCB:

-57.19%

Current Drawdown

ALT:

-99.78%

METCB:

-44.81%

Fundamentals

Market Cap

ALT:

$430.51M

METCB:

$483.77M

EPS

ALT:

-$1.34

METCB:

$0.11

PS Ratio

ALT:

21.53K

METCB:

0.73

PB Ratio

ALT:

3.34

METCB:

1.31

Total Revenue (TTM)

ALT:

$15.00K

METCB:

$493.62M

Gross Profit (TTM)

ALT:

-$79.00K

METCB:

$65.64M

EBITDA (TTM)

ALT:

-$70.53M

METCB:

$68.37M

Returns By Period

The year-to-date returns for both investments are quite close, with ALT having a -16.64% return and METCB slightly higher at -16.49%.


ALT

YTD

-16.64%

1M

36.28%

6M

-18.23%

1Y

-16.76%

5Y*

7.82%

10Y*

-35.97%

METCB

YTD

-16.49%

1M

7.60%

6M

-22.70%

1Y

-21.43%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALT vs. METCB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALT
The Risk-Adjusted Performance Rank of ALT is 4040
Overall Rank
The Sharpe Ratio Rank of ALT is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of ALT is 4545
Sortino Ratio Rank
The Omega Ratio Rank of ALT is 4343
Omega Ratio Rank
The Calmar Ratio Rank of ALT is 3838
Calmar Ratio Rank
The Martin Ratio Rank of ALT is 3737
Martin Ratio Rank

METCB
The Risk-Adjusted Performance Rank of METCB is 1616
Overall Rank
The Sharpe Ratio Rank of METCB is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of METCB is 1818
Sortino Ratio Rank
The Omega Ratio Rank of METCB is 2020
Omega Ratio Rank
The Calmar Ratio Rank of METCB is 1515
Calmar Ratio Rank
The Martin Ratio Rank of METCB is 11
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALT vs. METCB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Ramaco Resources Inc. (METCB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ALT Sharpe Ratio is -0.20, which is higher than the METCB Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of ALT and METCB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

ALT vs. METCB - Dividend Comparison

Neither ALT nor METCB has paid dividends to shareholders.


TTM20242023202220212020201920182017
ALT
Altimmune, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.87%
METCB
Ramaco Resources Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

ALT vs. METCB - Drawdown Comparison

The maximum ALT drawdown since its inception was -99.94%, which is greater than METCB's maximum drawdown of -57.19%. Use the drawdown chart below to compare losses from any high point for ALT and METCB. For additional features, visit the drawdowns tool.


Loading data...

Volatility

ALT vs. METCB - Volatility Comparison

Altimmune, Inc. (ALT) has a higher volatility of 22.15% compared to Ramaco Resources Inc. (METCB) at 19.99%. This indicates that ALT's price experiences larger fluctuations and is considered to be riskier than METCB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

ALT vs. METCB - Financials Comparison

This section allows you to compare key financial metrics between Altimmune, Inc. and Ramaco Resources Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
5.00K
170.89M
(ALT) Total Revenue
(METCB) Total Revenue
Values in USD except per share items